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founding factors that may affect liver stiff-
ness measurement. According to previous 
studies, liver stiffness measured using MRE 
could be overestimated in patients with ac-
tive hepatitis [5–7], whereas age, sex, race, 
and isolated fatty liver have not shown any 
significant association with liver stiffness [5, 
6, 8]. Furthermore, it has been reported that 
massive ascites, iron deposition, and high 
body mass index are associated with failure 
of MRE measurements in the liver [4, 9].
Transient elastography is a modality widely 
used to assess liver fibrosis by measuring liv-
er stiffness [10]. Liver stiffness measured by 
transient elastography has been strongly as-
sociated with the degree of liver fibrosis, and 
for acute biliary obstruction, a significant pos-
itive correlation has been reported between 
liver stiffness measured using transient elas-
tography and bilirubin levels [10–12]. In ad-
dition, liver stiffness decreased in patients af-
ter successful biliary drainage. It was believed 
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M
R elastography (MRE) is a quan-
titative imaging method based on 
MRI that directly measures liver 
stiffness. It generates and trans-
fers mechanical waves through the liver and 
obtains images of wave propagation in tissues. 
From this, the shear stiffness of tissue can be 
measured by calculating the shear-wave speed 
and the density of tissue using the equation 
μ = ρс2, where μ = shear module, ρ = density 
of tissue, and с = shear-wave speed. Compared 
with transient elastography, MRE permits 2D 
or 3D imaging of propagating waves within 
the liver, resulting in the assessment of a large 
volume of liver and, ultimately, more accurate 
diagnostic performance [1, 2]. According to 
previous studies, the diagnostic accuracy of 
MRE for differentiating fibrosis stages has 
been reported to have a sensitivity of up to 
98% and a specificity of 99% [3, 4].
Despite the higher accuracy of MRE for 
the diagnosis of liver fibrosis, there are con-
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OBJECTIVE. The purpose of this study is to evaluate the clinical effect of liver stiffness 
measured using MR elastography (MRE) in patients with cholestasis due to biliary obstruction. 
MATERIALS AND METHODS. In this retrospective study, 69 consecutive patients 
with no history of diffuse liver disease who underwent pancreaticobiliary imaging with MRE 
were included. Quantitative MRI parameters (i.e., liver stiffness, apparent diffusion coefficient, 
R2*, and proton density fat fraction) and laboratory results (i.e., aspartate aminotransferase, ala-
nine aminotransferase, and total bilirubin levels) were measured. Patients were classified as hav-
ing either normal bilirubin (group A; n = 49) or hyperbilirubinemia (group B; n = 20). Continu-
ous variables were compared using the independent t test or Mann-Whitney U test. Correlation 
between parameters was analyzed using the Pearson correlation coefficient. The ROC curve 
analysis was used to evaluate the diagnostic performance and clinical effect of MRE. 
RESULTS. Liver stiffness was significantly higher in group B (mean ± SD, 3.8 ± 0.7 kPa) 
than in group A (2.8 ± 0.5 kPa) (p < 0.001); there were no differences in other MRI param-
eters. There were positive correlations between liver stiffness and total bilirubin (r = 0.609; 
p < 0.001), aspartate aminotransferase (r = 0.376; p = 0.001), and alanine aminotransferase 
(r = 0.285; p = 0.017) levels. There was a negative correlation between the degree of biliary 
decompression 1 week after bile drainage and liver stiffness (r = −0.71; p = 0.003). The sensi-
tivity and specificity for predicting biliary decompression were 83.3% and 100%, respective-
ly, at a liver stiffness cutoff of 4.0 kPa. 
CONCLUSION. Liver stiffness measured by MRE increases as cholestasis increases and 
can be a predictive factor for the sufficiency of biliary decompression after biliary drainage. 
Kim et al.
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that the reason for the increase in liver stiff-
ness in cases of acute biliary obstruction may 
be the increased hydrostatic pressure due to 
impaired bile flow and accompanying tissue 
swelling, inflammation, and edema [10, 12]. 
On the basis of this information, we hypothe-
sized that liver stiffness measured using MRE 
could also be affected by biliary obstruction. 
Hence, the purpose of this study was to inves-
tigate the effect of liver stiffness measured us-
ing MRE in patients with cholestasis due to 
biliary obstruction. The effect of other quan-
titative MRI parameters, including apparent 
diffusion coefficient (ADC), T2* relaxation 
time, and proton density fat fraction (PDFF), 
on cholestasis were also evaluated. Further-
more, we investigated the clinical effect of liv-
er stiffness measured using MRE in patients 
with cholestasis due to biliary obstruction.
Materials and Methods
Study Population
This retrospective study was approved by our 
institutional review board. Given the retrospec-
tive nature of the investigation and the use of ano-
nymized patient data, requirements for informed 
consent were waived. Patients who underwent 
pancreaticobiliary MRI including MRE between 
September 2015 and August 2016 were eligible for 
inclusion in this study. Among them, patients who 
underwent blood chemistry examination, includ-
ing aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), and serum total bilirubin 
(TB) levels, at least 1 week before MRI were in-
cluded. However, patients with any history of dif-
fuse liver disease (e.g., chronic viral hepatitis B or 
C or liver cirrhosis due to any cause), those who 
underwent previous liver surgery, or those who 
consumed more than 14 units of alcohol per week 
(or 20 g/day) were excluded [13]. Patients enrolled 
in the study were divided into one of two groups: 
those with a TB level within normal limits (≤ 1.8 
mg/dL; group A) and those with hyperbilirubine-
mia (> 1.8 mg/dL; group B). Data on age, sex, and 
AST, ALT, and TB levels were collected from all 
patients. In patients with hyperbilirubinemia who 
underwent biliary decompression for biliary ob-
struction, TB levels 1 day and 1 week after biliary 
drainage were analyzed to assess the effectiveness 
of the procedure. The percentage of TB change 
before and after biliary decompression was calcu-
lated using the following formula: percentage bil-
irubin change = [(1 − TB level after procedure) / 
TB level before procedure] × 100.
MR Image Acquisition
MRI examinations were performed using a 3-T 
MRI scanner (Discovery 750w 3 T, GE Healthcare) 
equipped with a 32-channel torso coil. MRE was 
included in the routine pancreaticobiliary MRI 
protocol for the upper abdomen to determine the 
possibility of surgery or to evaluate the liver stiff-
ness of patients, if necessary. The routine pancre-
aticobiliary MRI protocol also included iterative 
decomposition of water and fat with echo asym-
metry and the least squares estimation, as well as 
DWI. MRE and iterative decomposition of water 
and fat with echo asymmetry and the least squares 
estimation were performed before the injection of 
contrast media. DW images were acquired after 
contrast-enhanced dynamic MRI because the gad-
olinium-based contrast agent does not significant-
ly alter the ADC [14]. MRE was performed ac-
cording to previously established methods [15]. In 
brief, axial slices were acquired using a 2D spin-
echo MRE technique. Mechanical waves with a 
frequency of 60 Hz were generated in the active 
driver, which was located outside the MRI room 
and transferred to a passive pneumatic driver via 
a plastic duct. The passive pneumatic driver was 
placed at the anterior wall of the right upper abdo-
men adjacent to the liver, and mechanical waves 
were transferred to the liver during MRE. The 
MR elastograms, quantitative images displaying 
shear stiffness, were generated by processing the 
sequence to collect axial wave images sensitized 
along the through-plane motion direction, which 
was previously described as a local frequency esti-
mation inversion algorithm [16]. Patients held their 
breath at the end of expiration at each section, and 
four slices of MR elastograms were obtained for 
each patient. Iterative decomposition of water and 
fat with echo asymmetry and the least squares es-
timation is a noninvasive 3D volumetric imaging 
sequence for creating R2* (1/T2*) and PDFF maps 
from a single breath-hold acquisition in the liver. 
Six different echoes were applied to separate wa-
ter and triglyceride fat, and PDFF and R2* maps 
were automatically reconstructed in the console 
[17, 18]. The DWI sequence was performed using 
three b values (50, 400, 800 s/mm2), and the ADC 
was generated in the MRI console. Detailed MRI 
parameters are summarized in Table 1.
Image Analysis
Quantitative measurements were performed by 
one radiologist by drawing an ROI (mean [± SD], ≈ 
339 ± 39.1 mm2; range, 300–400 mm2) on the right 
lobe of the liver on three contiguous images on the 
MR elastogram, R2* map, PDFF map, and ADC 
map. The ROIs were oval or circular and exclud-
ed the liver boundary, fissures, gallbladder fossa, 
artifacts, and large blood vessels. In terms of liv-
er stiffness measurement, a confidence map, which 
indicated areas of high confidence and acceptable 
signal-to-noise ratio, was initially reviewed, and an 
ROI was drawn within the high-confidence area 
[19]. Finally, the mean value of three measure-
ments in each sequence was calculated.
Furthermore, to exclude causes of hyperbili-
rubinemia other than biliary obstruction (e.g., he-
molysis, drug-induced liver disease, and genetic 
disorders, including Gilbert syndrome), the diam-
eter of the bile duct was measured where the bili-
ary dilatation was the greatest, including the intra-
hepatic duct and common bile duct, on axial CT 
images taken before the procedure, and the degree 
of diameter change in the bile duct (percentage) 
was measured on axial CT images taken after the 
procedure. The percentage difference in the de-
gree of diameter change in the bile duct was inves-
tigated between the group with sufficient biliary 
decompression and the group without sufficient 
biliary decompression, calculated as follows: per-
centage of bile duct diameter change = [(1 − bile 
TABLE 1: Parameters of MRI Sequences Used in This Study
Parameter Sequence TR/TE Matrix
Slice 
Thickness 
(mm)
Slice 
Spacing 
(mm)
Sensitivity 
Encoding
Flip Angle 
(°) Scan Time (s)
Iterative decomposition of water and 
fat with echo asymmetry and least 
squares estimation
Proton density fat 
fraction and R2*
6.3/2.9 160 × 160 12 12 2 3 19
Axial MRI Touch 1 MR elastography 1000.3/63.1 64 × 64 8 10 2 90 24a
Axial DWI (b = 50, 400, 800 s/mm2) Apparent diffusion 
coefficient
10,000/50.1 128 × 256 4 5 2 90 Variant (mean = 300)
Note—Touch 1 is an MR elastography protocol developed by GE Healthcare with the Mayo Clinic. 
aTotal scan time of 24 seconds for two 12-second scans to obtain the final MR elastogram.
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duct diameter after procedure) / bile duct diameter 
before procedure] × 100.
Statistical Analysis
Continuous variables are expressed as mean ± 
SD. Continuous variables with normal distribu-
tion, including quantitative MRI parameters and 
laboratory results, were compared between the 
two groups using the independent samples t test, 
and continuous variables without normal distri-
bution, such as changes in the bile duct diame-
ter (percentage), were compared between the two 
groups using the Mann-Whitney U test. Corre-
lations between liver stiffness and age and liver 
stiffness and other quantitative parameters were 
evaluated using the Pearson correlation coeffi-
cient. ROC analysis was conducted to assess the 
performance of MRE for predicting the efficiency 
of biliary decompression over a range of sensitiv-
ity and specificity values. The optimal cutoff value 
was chosen to maximize the sum of sensitivity and 
specificity. A p < 0.05 was considered to be sta-
tistically significant. All statistical analyses were 
performed using SPSS (version 21, IBM).
Results
Patients
Between September 2015 and August 
2016, 165 patients underwent pancreaticobil-
iary MRI including MRE; 44 patients were 
excluded because they did not undergo blood 
chemistry examination including AST, ALT, 
and serum TB levels at least 1 week before 
the MRI. An additional 49 patients with un-
derlying diffuse liver disease and three with 
a history of liver surgery were also exclud-
ed. Finally, a total of 69 patients (mean age, 
61.8 ± 12.7 years; 41 men and 28 women) 
were included in this study. Of these 69 pa-
tients, 49 were assigned to group A (mean 
age, 61.2 ± 12.5 years; 26 men and 23 wom-
en) and 20 were assigned to group B (mean 
age, 63.4 ± 13.6 years; 15 men and 5 women) 
(Fig. 1). Three patients in group A (one with a 
Eligible patients for assessing the quantitative
parameters of pancreaticobiliary MRI (n = 165)
Excluded patients (n = 96)
• Without blood chemistry examination
 including AST, ALT, and TB level at least 1
 week before MRI (n = 44)
• Underlying diffuse liver disease (n = 49)
• Prior liver surgery (n = 3)
Evaluation of quantitative MRI parameters
including PDFF, R2* value, ADC, and liver
stiffness (n = 69)
Group A with normal
TB level (n = 49)
Group B with 
cholestasis (n = 20)
Fig. 1—Flow diagram of study population. ALT = alanine aminotransferase, AST = aspartate aminotransferase, 
ADC = apparent diffusion coefficient, PDFF = proton density fat fraction, TB = total bilirubin.
TABLE 2: Demographics and Diagnoses of Patients Included in the Study
Characteristic Total (n = 69) Group A (n = 49) Group B (n = 20) p
Age (y), mean ± SD 61.8 ± 12.7 61.2 ± 12.5 63.4 ± 13.6 0.525
Sex, no. of patients 0.101
Male 41 26 15
Female 28 23 5
Aspartate aminotransferase level (IU/L), mean ± SD 42.7 ± 48.0 25.2 ± 13.7 87.6 ± 71.8 0.001
Alanine aminotransferase level (IU/L), mean ± SD 50.7 ± 70.8 25.2 ± 20.9 114.8 ± 107.2 0.002
Total bilirubin level (mg/dL), mean ± SD 2.6 ± 4.1 0.7 ± 0.3 7.6 ± 4.9 < 0.001
Reason for study, no. of patients 0.028
Pancreatic cancer 18 16 2
Pancreatic cyst 11 11 0
Ampulla of Vater cancer 3 1 2
Common bile duct cancer 15 4 11
Common bile duct stone 6 4 2
Carcinomatosis 2 1 1
Biliary stricture 2 1 1
Primary sclerosing cholangitis 2 1 1
Pancreatitis 6 6 0
Enzyme elevation 2 2 0
Gallbladder cancer 1 1 0
Gallbladder adenomyomatosis 1 1 0
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1.5-cm hemangioma in segment V, one with 
a 2.9-cm metastasis in segments II and III, 
and one with 0.8-, 1.2-, and 1.0-cm metas-
tases in segments II, IV, and I, respectively) 
and one patient in group B (1.7-cm metasta-
sis in segments V and VIII) had liver masses 
or metastases. There was no significant dif-
ference in age or sex between the two groups. 
However, AST level (25.2 ± 13.7 vs 87.6 ± 
71.8 IU/L; p = 0.001), ALT level (25.2 ± 20.9 
vs 114.8 ± 107.2 IU/L; p = 0.002), and TB 
level (0.7 ± 0.3 vs 7.6 ± 4.9 mg/dL; p < 0.001) 
were significantly higher in group B than in 
group A. The major indications for undergo-
ing pancreaticobiliary MRI included pancre-
atic cancer (26%), common bile duct cancer 
(22%), and pancreatic cyst (16%) (Table 2).
Quantitative Assessment of MRI Parameters
Liver stiffness measured using MRE was 
significantly higher in group B (3.8 ± 0.7 kPa) 
than in group A (2.8 ± 0.5 kPa) (p < 0.001). 
There was no significant difference between 
the two groups in terms of the other quantita-
tive MRI parameters, including PDFF (3.7 ± 
3.4 vs 2.7 ± 0.6; p = 0.257), R2* value (54.4 ± 
6.7 vs 50.8 ± 10.9 Hz; p = 0.106), or ADC 
(1.3 ± 0.2 × 10−3 vs 1.2 ± 0.2 × 10−3 mm2/s; 
p = 0.080) (Fig. 2). There were significant 
positive correlations between liver stiffness 
and TB level (r = 0.609; p < 0.001), as well 
as AST (r = 0.376; p = 0.001) and ALT (r = 
0.285; p = 0.017) levels (Fig. 3). In contrast, no 
significant correlation was found between liv-
er stiffness and R2* (p = 0.127; r = −0.19), or 
between liver stiffness and PDFF (p = 0.925; 
r = −0.01). Also, there was no significant dif-
ference in liver stiffness according to sex (p = 
0.073) and no significant correlation between 
liver stiffness and age (p = 0.907).
Predicting Biliary Decompression
Seventeen of 20 patients in group B under-
went biliary drainage procedures for decom-
pression, including endoscopic retrograde 
biliary drainage (n = 8) and percutaneous 
transhepatic biliary drainage without (n = 7) 
and with (n = 2) biliary stent insertion. There 
was a significant negative correlation between 
liver stiffness and the percentage change in 
TB level at 1 day (r = −0.55, p = 0.02) and 1 
week (r = −0.71; p = 0.003) after bile drain-
age (Fig. 4). Previous studies have defined 
successful biliary decompression as the de-
velopment of pneumobilia or improvement of 
intra- or extrahepatic dilatation on follow-up 
CT or MRI, with a decrease in TB level to 
less than 20% of the pretreatment value with-
in 7 days after the procedure [20, 21]. Accord-
ing to these criteria, 11 patients underwent 
successful biliary decompression, whereas 
four did not. TB was not evaluated 1 week af-
ter the procedure for two patients. The degree 
of diameter change in the bile duct (percent-
age) was not significantly different between 
the group with sufficient biliary decompres-
sion and the group without sufficient biliary 
decompression in the intrahepatic bile duct 
(46.1% ± 15.0% vs 28.7% ± 16.3%; p = 0.138) 
and common bile duct (53.1% ± 20.3% vs 
51.5% ± 4.7%; p = 0.376). At ROC analysis, a 
mean liver stiffness of less than 4.0 kPa rep-
resented a possible cutoff value for predicting 
sufficient biliary compression, with a sensi-
tivity of 83.3% and a specificity of 100% at 
1 week after the procedure (standard error, 
0.117; 95% CI, 0.638–0.896).
Discussion
Our results show that liver stiffness mea-
sured using MRE was significantly higher in 
patients with biliary obstruction compared 
with patients without biliary obstruction; pos-
itive correlations were found between liver 
stiffness and the levels of TB, AST, and ALT. 
Furthermore, using 4.0 kPa as the liver stiff-
ness cutoff value, MRE may be used to pre-
dict successful biliary decompression, with a 
sensitivity of 83.3% and specificity of 100%.
Previous studies have reported a significant 
positive correlation between liver stiffness 
and TB level [10, 22], which is consistent 
with our results. The exact reasons for high 
liver stiffness in patients with cholestasis are 
unknown, but it may be associated with ede-
ma, inflammation, tissue swelling, and in-
creased intracellular pressure caused by im-
paired bile flow [10, 12]. Moreover, there was 
a negative correlation between the degree of 
biliary decompression and liver stiffness in 
this study. Considering that biliary drainage 
quickly decreases hydrostatic pressure, as 
well as cellular edema or inflammation, we 
believe that patients with cholestasis showed 
increased liver stiffness because of multiple 
factors associated with biliary obstruction.
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Previous studies reported a low albumin 
level (< 3 g/100 mL), thrombocytopenia, 
high urea nitrogen level (> 20 mmol/L), and 
high creatinine level (> 1.2 mg/dL) as pre-
dictive factors for negative outcome of bili-
ary decompression [23, 24]. On the basis of 
our results, high liver stiffness measured us-
ing MRE may represent an additional nonin-
vasive imaging biomarker to predict the ef-
fectiveness of biliary decompression. If liver 
stiffness is less than 4.0 kPa before biliary 
drainage, successful biliary decompression 
could be expected in 83.3% of patients.
Although some studies have found that 
liver stiffness is affected by hepatic steato-
sis [25, 26], more recent investigations have 
reported no significant relationship between 
hepatic steatosis and liver stiffness [2, 5, 6, 
8]. Our results were comparable with recent 
studies that have reported no significant cor-
relation between liver stiffness and PDFF. In 
terms of R2*, which is usually used to evalu-
ate iron deposition in the liver [27, 28], there 
was no significant difference, regardless of 
the presence of biliary obstruction, suggest-
ing that R2* cannot be used to evaluate bili-
ary obstruction or to predict the sufficiency 
of biliary decompression.
There were some limitations to our study, 
the first of which was its retrospective de-
sign and inherent selection bias, which may 
have affected the results. Second, the number 
of patients who underwent bile drainage was 
relatively small and the methods of decom-
pression were variable. Third, we could not 
directly confirm the other causes of hyperbil-
irubinemia, in addition to biliary obstruction, 
because liver biopsies were not performed on 
the patients. Fourth, although the cause of im-
paired bile drainage was malignancy in most 
cases, the exact tumor burden in each pa-
tient was not considered; moreover, the exact 
range of liver segments in which bile drain-
age was accessible was not considered.
In conclusion, liver stiffness measured us-
ing MRE was increased in patients with cho-
lestasis; therefore, our results showed that 
liver stiffness should be interpreted with 
caution to avoid overdiagnosis of liver fibro-
sis stage. Furthermore, liver stiffness can be 
used as a noninvasive imaging biomarker for 
predicting successful biliary decompression 
after bile drainage.
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